Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Neoplasms 6Lung Neoplasms 5Glioblastoma 4Urinary Bladder Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Brain Neoplasms 3Pancreatic Neoplasms 2Lung Diseases 2Glioma 2Astrocytoma 2Uterine Cervical Neoplasms 1Tuberculosis, Pulmonary 1Thyroid Nodule 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Pulmonary Arterial Hypertension 1Prostatic Neoplasms 1Pleural Neoplasms 1Pancreatic Cyst 1Oropharyngeal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Pulmonary Nodules 1Mouth Neoplasms 1Mesothelioma 1Medication Adherence 1

Interventions

Temozolomide 163Radiosurgery 129Radiotherapy 107Bevacizumab 98Magnetic Resonance Spectroscopy 75Carboplatin 48Surgical Procedures, Operative 35pembrolizumab 34Radiation 34Etoposide 34Nivolumab 33Irinotecan 33Cyclophosphamide 33Erlotinib Hydrochloride 31Carmustine 28Lomustine 26Trastuzumab 25Cisplatin 25Ipilimumab 24Filgrastim 23Mental Status and Dementia Tests 21Magnetic Resonance Imaging 21Aminolevulinic Acid 21Vincristine 20Surveys and Questionnaires 19Capecitabine 19Topotecan 18Specimen Handling 18Pemetrexed 18Radiotherapy, Intensity-Modulated 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Brain Neoplasms × Drug Delivery Systems × Clear all
NCT05733312 2026-01-30

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Mayo Clinic

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT00431561 2013-12-03

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Isarna Therapeutics GmbH

Phase 2 Completed
141 enrolled
CNS

Astrocytoma, Brain Neoplasms, Camurati-Engelmann Syndrome, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡